Speaking from the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany, Jalid Sehouli, MD, of the Charité University of Medicine Berlin, Berlin, Germany, discusses a study to helping determine the quality of life in women with long-term survival from ovarian cancer, and suggests a role for preoperative c-reactive protein in predicting survival among long-term survivors of ovarian cancer.